300 related articles for article (PubMed ID: 12002233)
1. Hospital-acquired, laboratory-confirmed bloodstream infection: increased hospital stay and direct costs.
Orsi GB; Di Stefano L; Noah N
Infect Control Hosp Epidemiol; 2002 Apr; 23(4):190-7. PubMed ID: 12002233
[TBL] [Abstract][Full Text] [Related]
2. Hospital-acquired, laboratory-confirmed bloodstream infections: linking national surveillance data to clinical and financial hospital data to estimate increased length of stay and healthcare costs.
Vrijens F; Hulstaert F; Van de Sande S; Devriese S; Morales I; Parmentier Y
J Hosp Infect; 2010 Jul; 75(3):158-62. PubMed ID: 20381900
[TBL] [Abstract][Full Text] [Related]
3. The excess cost associated with healthcare-associated bloodstream infections at Auckland City Hospital.
Burns A; Bowers L; Pak NT; Wignall J; Roberts S
N Z Med J; 2010 Oct; 123(1324):17-24. PubMed ID: 20953218
[TBL] [Abstract][Full Text] [Related]
4. Cost of intensive care unit-acquired bloodstream infections.
Laupland KB; Lee H; Gregson DB; Manns BJ
J Hosp Infect; 2006 Jun; 63(2):124-32. PubMed ID: 16621137
[TBL] [Abstract][Full Text] [Related]
5. Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality.
Pittet D; Tarara D; Wenzel RP
JAMA; 1994 May; 271(20):1598-601. PubMed ID: 8182812
[TBL] [Abstract][Full Text] [Related]
6. Attributable cost of catheter-associated bloodstream infections among intensive care patients in a nonteaching hospital.
Warren DK; Quadir WW; Hollenbeak CS; Elward AM; Cox MJ; Fraser VJ
Crit Care Med; 2006 Aug; 34(8):2084-9. PubMed ID: 16763511
[TBL] [Abstract][Full Text] [Related]
7. Outcomes of nosocomial bloodstream infections in adult neutropenic patients: a prospective cohort and matched case-control study.
Wisplinghoff H; Cornely OA; Moser S; Bethe U; Stützer H; Salzberger B; Fätkenheuer G; Seifert H
Infect Control Hosp Epidemiol; 2003 Dec; 24(12):905-11. PubMed ID: 14700405
[TBL] [Abstract][Full Text] [Related]
8. Burden of bloodstream infection caused by extended-spectrum β-lactamase-producing enterobacteriaceae determined using multistate modeling at a Swiss University Hospital and a nationwide predictive model.
Stewardson A; Fankhauser C; De Angelis G; Rohner P; Safran E; Schrenzel J; Pittet D; Harbarth S
Infect Control Hosp Epidemiol; 2013 Feb; 34(2):133-43. PubMed ID: 23295559
[TBL] [Abstract][Full Text] [Related]
9. Estimating length of stay and inpatient charges attributable to hospital-acquired bloodstream infections.
Zhang Y; Du M; Johnston JM; Andres EB; Suo J; Yao H; Huo R; Liu Y; Fu Q
Antimicrob Resist Infect Control; 2020 Aug; 9(1):137. PubMed ID: 32811557
[TBL] [Abstract][Full Text] [Related]
10. Healthcare-associated Staphylococcus aureus bloodstream infection: length of stay, attributable mortality, and additional direct costs.
Primo MG; Guilarde AO; Martelli CM; Batista LJ; Turchi MD
Braz J Infect Dis; 2012; 16(6):503-9. PubMed ID: 23158266
[TBL] [Abstract][Full Text] [Related]
11. Nosocomial methicillin-resistant and methicillin-susceptible Staphylococcus aureus primary bacteremia: at what costs?
Abramson MA; Sexton DJ
Infect Control Hosp Epidemiol; 1999 Jun; 20(6):408-11. PubMed ID: 10395142
[TBL] [Abstract][Full Text] [Related]
12. Comparative impact of hospital-acquired infections on medical costs, length of hospital stay and outcome between community hospitals and medical centres.
Sheng WH; Wang JT; Lu DC; Chie WC; Chen YC; Chang SC
J Hosp Infect; 2005 Mar; 59(3):205-14. PubMed ID: 15694977
[TBL] [Abstract][Full Text] [Related]
13. Are there differences in hospital cost between patients with nosocomial methicillin-resistant Staphylococcus aureus bloodstream infection and those with methicillin-susceptible S. aureus bloodstream infection?
Ben-David D; Novikov I; Mermel LA
Infect Control Hosp Epidemiol; 2009 May; 30(5):453-60. PubMed ID: 19344266
[TBL] [Abstract][Full Text] [Related]
14. Costs and savings associated with infection control measures that reduced transmission of vancomycin-resistant enterococci in an endemic setting.
Montecalvo MA; Jarvis WR; Uman J; Shay DK; Petrullo C; Horowitz HW; Wormser GP
Infect Control Hosp Epidemiol; 2001 Jul; 22(7):437-42. PubMed ID: 11583213
[TBL] [Abstract][Full Text] [Related]
15. Prolongation of hospital stay and additional costs due to nosocomial bloodstream infection in an Algerian neonatal care unit.
Atif ML; Sadaoui F; Bezzaoucha A; Kaddache CA; Boukari R; Djelato S; Boubechou N
Infect Control Hosp Epidemiol; 2008 Nov; 29(11):1066-70. PubMed ID: 18826372
[TBL] [Abstract][Full Text] [Related]
16. Outcome and attributable cost of ventilator-associated pneumonia among intensive care unit patients in a suburban medical center.
Warren DK; Shukla SJ; Olsen MA; Kollef MH; Hollenbeak CS; Cox MJ; Cohen MM; Fraser VJ
Crit Care Med; 2003 May; 31(5):1312-7. PubMed ID: 12771596
[TBL] [Abstract][Full Text] [Related]
17. Adverse drug events in hospitalized patients. Excess length of stay, extra costs, and attributable mortality.
Classen DC; Pestotnik SL; Evans RS; Lloyd JF; Burke JP
JAMA; 1997 Jan 22-29; 277(4):301-6. PubMed ID: 9002492
[TBL] [Abstract][Full Text] [Related]
18. Daily cost of antimicrobial therapy in patients with Intensive Care Unit-acquired, laboratory-confirmed bloodstream infection.
Vandijck DM; Depaemelaere M; Labeau SO; Depuydt PO; Annemans L; Buyle FM; Oeyen S; Colpaert KE; Peleman RP; Blot SI; Decruyenaere JM
Int J Antimicrob Agents; 2008 Feb; 31(2):161-5. PubMed ID: 18164599
[TBL] [Abstract][Full Text] [Related]
19. Effect of nosocomial bloodstream infections on mortality, length of stay, and hospital costs in older adults.
Kaye KS; Marchaim D; Chen TY; Baures T; Anderson DJ; Choi Y; Sloane R; Schmader KE
J Am Geriatr Soc; 2014 Feb; 62(2):306-11. PubMed ID: 24438554
[TBL] [Abstract][Full Text] [Related]
20. The impact of surgical-site infections following orthopedic surgery at a community hospital and a university hospital: adverse quality of life, excess length of stay, and extra cost.
Whitehouse JD; Friedman ND; Kirkland KB; Richardson WJ; Sexton DJ
Infect Control Hosp Epidemiol; 2002 Apr; 23(4):183-9. PubMed ID: 12002232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
